Breast cancer screening in women over age 50. A critical appraisal. 1990

P H Peeters, and A L Verbeek, and G A Zielhuis, and G P Vooijs, and J H Hendriks, and M Mravunac
Department of Epidemiology, University Hospital Nijmegen, The Netherlands.

Breast cancer screening with mammography is strongly advocated by some and rejected by others. Discussions in the medical literature focus on the beneficial and unfavourable effects of breast cancer screening. Among the latter are the suggested excess mortality rate of screen-detected breast cancer patients, the high number of unnecessary biopsies, the possibility of overdiagnosis and subsequent unnecessary treatment, and the occurrence of interval breast cancer cases. It is concluded that screening can to a certain extent prevent women from dying of breast cancer but some negative effects are unavoidable. However, adequate training of the screening team can minimize the number of unnecessary biopsies and the occurrence of interval cancers. Research is needed to evaluate the natural course of so-called 'minimal' lesions, and to optimize screening tests. The search for new (imaging) techniques is needed to detect lobular cancers in dense breasts.

UI MeSH Term Description Entries
D008327 Mammography Radiographic examination of the breast. 3D-Mammography,Digital Breast Tomosynthesis,Digital Mammography,X-ray Breast Tomosynthesis,3D Mammography,3D-Mammographies,Breast Tomosyntheses, Digital,Breast Tomosyntheses, X-ray,Breast Tomosynthesis, Digital,Breast Tomosynthesis, X-ray,Digital Breast Tomosyntheses,Digital Mammographies,Mammographies,Mammographies, Digital,Mammography, Digital,X ray Breast Tomosynthesis,X-ray Breast Tomosyntheses
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011829 Radiation Dosage The amount of radiation energy that is deposited in a unit mass of material, such as tissues of plants or animal. In RADIOTHERAPY, radiation dosage is expressed in gray units (Gy). In RADIOLOGIC HEALTH, the dosage is expressed by the product of absorbed dose (Gy) and quality factor (a function of linear energy transfer), and is called radiation dose equivalent in sievert units (Sv). Sievert Units,Dosage, Radiation,Gray Units,Gy Radiation,Sv Radiation Dose Equivalent,Dosages, Radiation,Radiation Dosages,Units, Gray,Units, Sievert
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001706 Biopsy Removal and pathologic examination of specimens from the living body. Biopsies
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

P H Peeters, and A L Verbeek, and G A Zielhuis, and G P Vooijs, and J H Hendriks, and M Mravunac
January 2014, Journal of general internal medicine,
P H Peeters, and A L Verbeek, and G A Zielhuis, and G P Vooijs, and J H Hendriks, and M Mravunac
June 1991, Lancet (London, England),
P H Peeters, and A L Verbeek, and G A Zielhuis, and G P Vooijs, and J H Hendriks, and M Mravunac
April 2001, Medicine and health, Rhode Island,
P H Peeters, and A L Verbeek, and G A Zielhuis, and G P Vooijs, and J H Hendriks, and M Mravunac
December 1997, Annals of internal medicine,
P H Peeters, and A L Verbeek, and G A Zielhuis, and G P Vooijs, and J H Hendriks, and M Mravunac
May 1982, AJR. American journal of roentgenology,
P H Peeters, and A L Verbeek, and G A Zielhuis, and G P Vooijs, and J H Hendriks, and M Mravunac
March 1997, BMJ (Clinical research ed.),
P H Peeters, and A L Verbeek, and G A Zielhuis, and G P Vooijs, and J H Hendriks, and M Mravunac
June 1993, BMJ (Clinical research ed.),
P H Peeters, and A L Verbeek, and G A Zielhuis, and G P Vooijs, and J H Hendriks, and M Mravunac
September 2004, Preventive medicine,
P H Peeters, and A L Verbeek, and G A Zielhuis, and G P Vooijs, and J H Hendriks, and M Mravunac
January 2012, Revue de l'infirmiere,
P H Peeters, and A L Verbeek, and G A Zielhuis, and G P Vooijs, and J H Hendriks, and M Mravunac
January 2022, Current opinion in oncology,
Copied contents to your clipboard!